Is 4 Weeks of Glecaprevir/Pibrentasvir Sufficient to Treat Early Hepatitis C Infection?

Treatment of hepatitis C virus (HCV) during the early phase (within 24 weeks of infection) can reduce risk of transmission and lower healthcare costs compared to deferring treatment to the chronic phase.1 Modern oral direct-acting antivirals…

Continue Reading